Versatile biomanufacturing through stimulus-responsive cell–material feedback

Small-scale production of biologics has great potential for enhancing the accessibility of biomanufacturing. By exploiting cell–material feedback, we have designed a concise platform to achieve versatile production, analysis and purification of diverse proteins and protein complexes. The core of our technology is a microbial swarmbot, which consists of a stimulus-sensitive polymeric microcapsule encapsulating engineered bacteria. By sensing the confinement, the bacteria undergo programmed partial lysis at a high local density. Conversely, the encapsulating material shrinks responding to the changing chemical environment caused by cell growth, squeezing out the protein products released by bacterial lysis. This platform is then integrated with downstream modules to enable quantification of enzymatic kinetics, purification of diverse proteins, quantitative control of protein interactions and assembly of functional protein complexes and multienzyme metabolic pathways. Our work demonstrates the use of the cell–material feedback to engineer a modular and flexible platform with sophisticated yet well-defined programmed functions.Encapsulation of engineered bacteria in environmentally responsive materials enables on-demand protein production coupled to downstream processes such as protein purification, on-chip enzyme kinetics and metabolic production of fatty acids.

[1]  A. Chilkoti,et al.  Injectable protease-operated depots of glucagon-like peptide-1 provide extended and tunable glucose control , 2013, Proceedings of the National Academy of Sciences.

[2]  Karan Sukhija,et al.  A Single-use Strategy to Enable Manufacturing of Affordable Biologics , 2016, Computational and structural biotechnology journal.

[3]  R. Fleischmann,et al.  High quality protein microarray using in situ protein purification , 2009, BMC biotechnology.

[4]  L. Tsimring,et al.  A stabilized microbial ecosystem of self-limiting bacteria using synthetic quorum-regulated lysis , 2017, Nature Microbiology.

[5]  J. Mecsas,et al.  Bacterial Secretion Systems: An Overview , 2016, Microbiology spectrum.

[6]  Huub Schellekens,et al.  Making individualized drugs a reality , 2017, Nature Biotechnology.

[7]  Nicolas E. Buchler,et al.  Programming stress-induced altruistic death in engineered bacteria , 2012, Molecular systems biology.

[8]  James J. Collins,et al.  Portable, On-Demand Biomolecular Manufacturing , 2016, Cell.

[9]  A. Kjøniksen,et al.  Effects of ionic strength on the size and compactness of chitosan nanoparticles , 2012, Colloid and Polymer Science.

[10]  J. Cronan,et al.  The Burkholderia cenocepacia BDSF quorum sensing fatty acid is synthesized by a bifunctional crotonase homologue having both dehydratase and thioesterase activities , 2012, Molecular microbiology.

[11]  S. Quake,et al.  Long-Term Monitoring of Bacteria Undergoing Programmed Population Control in a Microchemostat , 2005, Science.

[12]  Nigel Allison,et al.  Current status and future trends for disposable technology in the biopharmaceutical industry , 2014 .

[13]  M. Omar Din,et al.  Synchronized cycles of bacterial lysis for in vivo delivery , 2016, Nature.

[14]  M. Burkart,et al.  Mechanism-based protein cross-linking probes to investigate carrier protein-mediated biosynthesis. , 2006, ACS chemical biology.

[15]  A. Gutowska,et al.  Squeezing hydrogels for controlled oral drug delivery , 1997 .

[16]  Florian David,et al.  Reprogramming Yeast Metabolism from Alcoholic Fermentation to Lipogenesis , 2018, Cell.

[17]  E. Redwan,et al.  Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives. , 2015, Journal of microbiology and biotechnology.

[18]  X Huang,et al.  On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[19]  D. Needham,et al.  Investigation of the Swelling Response and Loading of Ionic Microgels with Drugs and Proteins: The Dependence on Cross-Link Density , 1999 .

[20]  Alan Dove,et al.  Uncorking the biomanufacturing bottleneck , 2002, Nature Biotechnology.

[21]  C. Collins,et al.  Modular optimization of multi-gene pathways for fatty acids production in E. coli , 2013, Nature Communications.

[22]  Kurt Brorson,et al.  The need for innovation in biomanufacturing , 2012, Nature Biotechnology.

[23]  S. Kubick,et al.  A Continuous-Exchange Cell-Free Protein Synthesis System Based on Extracts from Cultured Insect Cells , 2014, PloS one.

[24]  R. Heath,et al.  Enoyl-Acyl Carrier Protein Reductase (fabI) Plays a Determinant Role in Completing Cycles of Fatty Acid Elongation in Escherichia coli(*) , 1995, The Journal of Biological Chemistry.

[25]  Tingrui Pan,et al.  Synthetic microbial consortia enable rapid assembly of pure translation machinery. , 2018, Nature chemical biology.

[26]  F. Arnold,et al.  Synthesis of bioactive protein hydrogels by genetically encoded SpyTag-SpyCatcher chemistry , 2014, Proceedings of the National Academy of Sciences.

[27]  B. Seijo,et al.  Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior. , 2005, Journal of colloid and interface science.

[28]  Adriana G. Lopes,et al.  Single-use in the biopharmaceutical industry: A review of current technology impact, challenges and limitations , 2015 .

[29]  A. Ashok,et al.  Improving cold chain systems: Challenges and solutions. , 2017, Vaccine.

[30]  F. Mergulhão,et al.  Secretion Capacity Limitations of the Sec Pathway in Escherichia coli , 2004 .

[31]  Benjamin C. Tang,et al.  Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery. , 2013, ACS nano.

[32]  Ashutosh Chilkoti,et al.  Purification of recombinant proteins by fusion with thermally-responsive polypeptides , 1999, Nature Biotechnology.

[33]  David K. Karig,et al.  Metabolic division of labor in microbial systems , 2018, Proceedings of the National Academy of Sciences.

[34]  M. Rotondi,et al.  Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. , 2000, The Journal of clinical endocrinology and metabolism.

[35]  David K. Karig,et al.  Preservation of protein expression systems at elevated temperatures for portable therapeutic production , 2017, Journal of The Royal Society Interface.

[36]  D. Kohane,et al.  HYDROGELS IN DRUG DELIVERY: PROGRESS AND CHALLENGES , 2008 .

[37]  Gary Walsh,et al.  Biopharmaceutical benchmarks 2014 , 2014, Nature Biotechnology.

[38]  Paul Yager,et al.  Cell lysis and protein extraction in a microfluidic device with detection by a fluorogenic enzyme assay. , 2002, Analytical chemistry.

[39]  A. Chilkoti,et al.  Purification of an elastin‐like fusion protein by microfiltration , 2006, Biotechnology and bioengineering.

[40]  Joseph D Puglisi,et al.  Quantitative polysome analysis identifies limitations in bacterial cell-free protein synthesis. , 2005, Biotechnology and bioengineering.

[41]  D. Summers,et al.  Recombinant protein secretion in Escherichia coli. , 2005, Biotechnology advances.

[42]  Tiangang Liu,et al.  In vitro reconstitution and steady-state analysis of the fatty acid synthase from Escherichia coli , 2011, Proceedings of the National Academy of Sciences.

[43]  Timothy K Lu,et al.  Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care , 2016, Nature Communications.

[44]  Lingchong You,et al.  Coupling spatial segregation with synthetic circuits to control bacterial survival , 2016, Molecular systems biology.

[45]  Yu Tanouchi,et al.  Oscillations by Minimal Bacterial Suicide Circuits Reveal Hidden Facets of Host-Circuit Physiology , 2010, PloS one.

[46]  Uwe Gottschalk,et al.  Single-use disposable technologies for biopharmaceutical manufacturing. , 2013, Trends in biotechnology.

[47]  James J. Collins,et al.  Paper-Based Synthetic Gene Networks , 2014, Cell.

[48]  L. You,et al.  Synthetic Biology Looks Good on Paper , 2014, Cell.

[49]  C. Bewley,et al.  Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential , 2016, Viruses.

[50]  Patient-centered drug manufacture , 2017, Nature Biotechnology.

[51]  L. Thöny-Meyer,et al.  Production of glycoprotein vaccines in Escherichia coli , 2010, Microbial cell factories.

[52]  David K. Karig,et al.  Antibiotics as a selective driver for conjugation dynamics , 2016, Nature Microbiology.

[53]  Geoffrey S F Ling,et al.  Battlefield Medicine: Paradigm Shift for Pharmaceuticals Manufacturing , 2014, PDA Journal of Pharmaceutical Science and Technology.